Summary
McKesson Corporation (MCK) filed an 8-K on May 12, 2015, to announce its preliminary financial results for the fourth quarter and full fiscal year ended March 31, 2015. This filing is critical for investors as it provides an early look at the company's performance, including revenue and earnings, which can significantly influence stock valuation and future expectations. The press release attached as Exhibit 99.1 contains the core financial information. Investors should pay close attention to the key financial metrics disclosed, such as revenue growth, profitability, and any forward-looking guidance provided, as these will be crucial for understanding McKesson's operational health and strategic positioning in the pharmaceutical distribution and healthcare services sector.
Key Highlights
- 1McKesson Corporation filed an 8-K on May 12, 2015, announcing preliminary results for Q4 and FY15.
- 2The filing serves to inform investors about the company's financial performance as of March 31, 2015.
- 3The key information is contained within an attached press release (Exhibit 99.1).
- 4The report covers the fiscal fourth quarter and the full fiscal year ended March 31, 2015.
- 5The company is providing these results to the SEC via a Form 8-K filing.
- 6The filing is furnished to the SEC and not deemed 'filed' for Section 18 purposes, nor automatically incorporated into other filings.